LEVIN CAPITAL STRATEGIES, L.P. - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 56 filers reported holding SUMMIT THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.

Quarter-by-quarter ownership
LEVIN CAPITAL STRATEGIES, L.P. ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$73,259
-25.5%
39,1760.0%0.01%
-18.2%
Q2 2023$98,332
+43.4%
39,1760.0%0.01%
+37.5%
Q1 2023$68,558
-58.8%
39,1760.0%0.01%
-63.6%
Q4 2022$166,498
+254.3%
39,1760.0%0.02%
+266.7%
Q3 2022$47,000
+20.5%
39,1760.0%0.01%
+20.0%
Q2 2022$39,000
-63.9%
39,176
-11.3%
0.01%
-50.0%
Q1 2022$108,000
-9.2%
44,1760.0%0.01%
-9.1%
Q4 2021$119,000
-45.7%
44,176
+0.9%
0.01%
-50.0%
Q3 2021$219,000
-24.2%
43,762
+12.9%
0.02%
-24.1%
Q2 2021$289,000
+46.7%
38,762
+15.7%
0.03%
+38.1%
Q1 2021$197,00033,5000.02%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Alpine Global Management, LLC 300,000$300,0000.08%
Polar Capital Holdings Plc 5,599,407$5,599,0000.03%
VANCE WEALTH, INC. 13,299$13,0000.01%
LEVIN CAPITAL STRATEGIES, L.P. 39,176$39,0000.01%
BENDER ROBERT & ASSOCIATES 14,059$14,0000.01%
HoyleCohen, LLC 30,432$30,0000.00%
Inscription Capital, LLC 17,000$17,0000.00%
Ergoteles LLC 100,722$101,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 89,100$89,0000.00%
ADIRONDACK TRUST CO 2,500$3,0000.00%
View complete list of SUMMIT THERAPEUTICS INC shareholders